T955-1055 Screening compound: 1-[3-(3-{2-[(oxan-4-yl)methoxy]ethyl}-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-2-(pyridin-3-yl)ethan-1-one

T955-1055 Screening compound: 1-[3-(3-{2-[(oxan-4-yl)methoxy]ethyl}-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-2-(pyridin-3-yl)ethan-1-one
T955-1055 Screening compound: 1-[3-(3-{2-[(oxan-4-yl)methoxy]ethyl}-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-2-(pyridin-3-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound T955-1055
1-[3-(3-{2-[(oxan-4-yl)methoxy]ethyl}-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-2-(pyridin-3-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T955-1055

Molecular Formula

C22H30N4O4 (C22 H30 N4 O4)

Compound Name

1-[3-(3-{2-[(oxan-4-yl)methoxy]ethyl}-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-2-(pyridin-3-yl)ethan-1-one

IUPAC name

1-[3-(3-{2-[(oxan-4-yl)methoxy]ethyl}-124-oxadiazol-5-yl)piperidin-1-yl]-2-(pyridin-3-yl)ethan-1-one

SMILES

O=C(Cc1cnccc1)N(CCC1)CC1c1nc(CCOCC2CCOCC2)no1

InChI

InChI=1S/C22H30N4O4/c27-21(13-18-3-1-8-23-14-18)26-9-2-4-19(15-26)22-24-20(25-30-22)7-12-29-16-17-5-10-28-11-6-17/h1,3,8,14,17,19H,2,4-7,9-13,15-16H2/t19-/m0/s1

InChI Key

RTRPNDXRWDUNCH-IBGZPJMESA-N

MDL Number (MFCD)

MFCD31972599

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

414.5

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.865

Distribution Coefficient, logD

1.856

Water Solubility, LogSw

-1.26

Polar Surface Area

74.661

Acid Dissociation Constant (pKa)

15.08

Base Dissociation Constant (pKb)

5.70

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

63.64

T955-1055 in Drug Discovery

Included in Screening Libraries

Autophagy-Targeted Library (4564 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T955-1055 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T955-1055?
Check Price and Availability of T955-1055, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T955-1055 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T955-1055
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T955-1055
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T955-1055 available by request